Page last updated: 2024-08-22

platinum and Carcinoma, Adenosquamous

platinum has been researched along with Carcinoma, Adenosquamous in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Y; Chen, H; Gao, Z; Han, B; Jiang, G; Li, X; Lu, D; Qian, J; Su, B; Tan, X; Wang, J; Wang, S; Wu, Q; Yang, Y; Zhao, X1
De Souza, AL; Saif, MW2
Crysandt, M; Esser, A; Jost, E; Osieka, R; von Hobe, S; Wilop, S1
Hamana, S; Ku, Y; Maruo, T; Miyahara, Y; Motoyama, S; Takeuchi, S; Tateiwa, Y; Yoshida, S1

Trials

1 trial(s) available for platinum and Carcinoma, Adenosquamous

ArticleYear
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: I. Analysis for pharmacokinetics, tumor response, and toxicity of platinum.
    American journal of clinical oncology, 2001, Volume: 24, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Feasibility Studies; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Neoplasm Staging; Platinum; Uterine Neoplasms

2001

Other Studies

4 other study(ies) available for platinum and Carcinoma, Adenosquamous

ArticleYear
Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
    Clinical lung cancer, 2014, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Genotype; Haplotypes; Hematologic Diseases; Histocompatibility Antigens Class II; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis

2014
Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions.
    JOP : Journal of the pancreas, 2014, Mar-10, Volume: 15, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Humans; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Platinum; Treatment Outcome

2014
Squamous cell carcinoma of the pancreas.
    JOP : Journal of the pancreas, 2014, Nov-28, Volume: 15, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Humans; Pancreatic Neoplasms; Platinum

2014
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Middle Aged; Platinum; Prognosis; Retrospective Studies; Survival Rate

2009